DIVINHEALSimplifying Global Wellbeing
HOME
TREATMENTS
HOSPITALS
Page background

PGT-A/PGT-M (Genetic Testing of Embryos) Success Rate in New Delhi

Content updated at: February 19, 2026

About

PGT-A/PGT-M (Genetic Testing of Embryos) Success Rate in New Delhi

Understanding the PGT-A/PGT-M (Genetic Testing of Embryos) success rate is crucial for individuals pursuing fertility treatments in New Delhi. This diagnostic tool significantly impacts the journey towards a successful pregnancy, influencing decisions and expectations. The ultimate success relies on various factors, including the specific testing method, the underlying cause of infertility, and individual patient profiles. New Delhi has established itself as a prominent destination for advanced fertility care and data-reviewed outcomes.

Evaluating PGT-A/PGT-M outcomes in New Delhi involves reviewing aggregated clinical data from various leading fertility centers. Success rates are carefully assessed and compared against established benchmarks to ensure transparency and accuracy. It is important to note that reported outcomes can vary based on the specific laboratory protocols, patient demographics, and the definition of 'success' being considered. These evaluations contribute to a clearer understanding of treatment efficacy in the region.

Defining Success for PGT-A/PGT-M (Genetic Testing of Embryos)

For PGT-A/PGT-M (Genetic Testing of Embryos), 'success' encompasses several critical milestones rather than a single event. Initially, it refers to the successful biopsy of embryos and the accurate identification of euploid (chromosomally normal) or unaffected embryos. The broader definition extends to the successful implantation of such an embryo, leading to a clinical pregnancy, and ultimately, a live birth. Short-term success involves viable embryo selection, while long-term success is a healthy baby.

PGT-A/PGT-M (Genetic Testing of Embryos) Success Rate Breakdown

Success rates for PGT-A/PGT-M (Genetic Testing of Embryos) vary depending on the specific testing approach and various patient factors.

Treatment Type / Category Typical Use Case Success Rate Range (%) What Success Indicates
PGT-A (Preimplantation Genetic Testing for Aneuploidy) Screening embryos for chromosomal abnormalities in IVF cycles, especially for advanced maternal age or recurrent implantation failure. 50%–70% Live birth rate per euploid embryo transfer, reflecting the chance of a healthy pregnancy after transfer.
PGT-M (Preimplantation Genetic Testing for Monogenic Disease) Identifying embryos free from specific inherited genetic conditions (e.g., cystic fibrosis, Huntington's disease) in couples who are carriers. 45%–65% Live birth rate per unaffected embryo transfer, indicating successful prevention of passing on a known genetic disorder.

PGT-A/PGT-M (Genetic Testing of Embryos) Survival Rate by Age in New Delhi

The success and survival rates associated with PGT-A/PGT-M (Genetic Testing of Embryos) are significantly influenced by maternal age, a trend consistently observed globally and within New Delhi's clinics. Older maternal age is generally linked to a higher incidence of aneuploidy in embryos. Consequently, the chance of identifying a euploid embryo suitable for transfer decreases with advancing age, directly impacting the overall live birth rate. These outcome trends align with internationally observed clinical practices and research findings.

Age Group Primary Consideration Euploid Embryo Rate Range (%) Live Birth Rate per Transfer Range (%)
Under 35 years Generally higher egg quality, lower aneuploidy risk. 55%–75% 45%–60%
35–37 years Moderate decline in egg quality, increasing aneuploidy risk. 40%–60% 35%–50%
38–40 years Significant increase in aneuploidy, further decline in egg quality. 25%–45% 25%–40%
Over 40 years High aneuploidy rates, fewer euploid embryos expected. 10%–25% 10%–25%

PGT-A/PGT-M (Genetic Testing of Embryos) Success Rate in New Delhi vs. Global Outcomes

Success rates for PGT-A/PGT-M (Genetic Testing of Embryos) in New Delhi are often comparable with international standards. This holds true when leading clinics in the city adhere to similar stringent protocols, utilize advanced laboratory technology, and apply appropriate patient selection criteria. The PGT-A/PGT-M (Genetic Testing of Embryos) survival rate in New Delhi mirrors global trends for similar demographic profiles.

Region/Country Live Birth Rate per Euploid Embryo Transfer Range (%)
New Delhi (India) 40%–55%
United States 45%–60%
United Kingdom 40%–55%
Australia 40%–58%
Spain 42%–57%
Canada 40%–55%
Czech Republic 38%–52%

Disclaimer: These rates are indicative averages, not a guarantee of individual outcomes. Actual results vary based on specific patient conditions and clinical approach.

Factors Influencing PGT-A/PGT-M (Genetic Testing of Embryos) Success Rate in New Delhi

  • Maternal age: A primary determinant of embryo quality and euploidy.
  • Number and quality of embryos available for biopsy and transfer.
  • Underlying cause of infertility: Affects overall IVF and PGT outcomes.
  • Laboratory expertise and technology: Crucial for accurate testing and embryo handling.
  • Specific genetic condition being screened for (for PGT-M).
  • Uterine receptivity and overall patient health.
  • Embryo biopsy technique and subsequent embryo vitrification/thaw success.
  • Experience of the embryology and clinical team in the center.

Data Sources & Methodology for PGT-A/PGT-M (Genetic Testing of Embryos) Outcomes

  • Aggregated clinical data from multiple leading fertility centers in New Delhi.
  • Peer-reviewed scientific literature and medical studies on PGT efficacy.
  • Reports from national and international fertility registries (where applicable).
  • Guidelines and recommendations from professional bodies like the Indian Council of Medical Research (ICMR).
  • Leading centers often contribute data to registries, informing the average PGT-A/PGT-M (Genetic Testing of Embryos) recovery rate in New Delhi.

Informed Choices for PGT-A/PGT-M

Understanding the realistic PGT-A/PGT-M (Genetic Testing of Embryos) success rate in New Delhi empowers patients. This knowledge helps in making confident, data-driven decisions during their fertility journey, ensuring clarity and transparency.

Hospitals Offering this treatment

India offers premium medical procedures at affordable prices. Discover our most popular treatments, delivered by the country's finest doctors.

Meet Our Doctors

Meet our team of highly qualified and experienced medical professionals dedicated to providing the best healthcare services.

Dr. Abhinandan Mukhopadhyay

Dr. Abhinandan Mukhopadhyay

Sr. Consultant - Urology & Kidney Transplant Program (Unit I)

Urology, Kidney Transplant, Urological Cancers

Haryana

8+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Amit Kalsotra

Dr. Amit Kalsotra

Sr. Consultant - Anaesthesia, Critical Care & Pain Management

Anaesthesia, Critical Care, Pain Management

New Delhi

15+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Aditya Gupta

Dr. Aditya Gupta

Chairperson - Neurosurgery & CNS Radiosurgery & Co-Chief - Cyberknife Centre

Neurosurgery

New Delhi

32+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Chakraberty

Dr. Chakraberty

Chief - Emergency

Emergency & Trauma Services

New Delhi

25+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Deepak Jha

Dr. Deepak Jha

Chief - Breast Surgery & Sr. Consultant : Surgical Oncology

Breast Surgery, Oncology

New Delhi

15+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Meenal Thakral

Dr. Meenal Thakral

Attending Consultant – Geriatric Medicine

Geriatric Medicine, Geriatric Surgery

New Delhi

3+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Tapan Singh Chauhan

Dr. Tapan Singh Chauhan

Sr. Consultant - Surgical Oncology, Robotics, GI & HPB, Gynae & Peritoneal Surface Oncology

Oncology, Robotic Surgery

New Delhi

15+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Varun Mittal

Dr. Varun Mittal

Head - Kidney Transplant & Associate Chief - Uro-Oncology & Robotic Surgery (Unit I)

Nephrology, Organ Transplant, Robotic Surgery, Urology

New Delhi

15+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Nitin Goel

Dr. Nitin Goel

Sr. Consultant

Paediatric Surgery

New Delhi

10+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. S. V. Kotwal

Dr. S. V. Kotwal

Chairperson Emeritus and DNB Teacher - Urology

Urology

New Delhi

15+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details

Related Links

Ready To Start Your Healing Journey?

Get Personalized Medical Treatment Options From India's Top Hospitals. Our Medical Experts Are Ready To Assist You Every Step Of The Way.